BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2607 related articles for article (PubMed ID: 29145896)

  • 21. miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma.
    Mei LL; Wang WJ; Qiu YT; Xie XF; Bai J; Shi ZZ
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28832500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-516b functions as a tumor suppressor by directly modulating CCNG1 expression in esophageal squamous cell carcinoma.
    Zhao Y; Wang Y; Xing G
    Biomed Pharmacother; 2018 Oct; 106():1650-1660. PubMed ID: 30119241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.
    Li P; Liu X; Dong ZM; Ling ZQ
    Oncotarget; 2015 Nov; 6(35):38151-65. PubMed ID: 26510908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-615-5p targets insulin-like growth factor 2 and exerts tumor-suppressing functions in human esophageal squamous cell carcinoma.
    Yang B; Xie R; Wu SN; Gao CC; Yang XZ; Zhou JF
    Oncol Rep; 2018 Jan; 39(1):255-263. PubMed ID: 29115555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE.
    Jing R; Chen W; Wang H; Ju S; Cong H; Sun B; Jin Q; Chu S; Xu L; Cui M
    Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G719-29. PubMed ID: 26316588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
    Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
    J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
    Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.
    Mao Y; Liu J; Zhang D; Li B
    Tumour Biol; 2016 Jul; 37(7):9009-22. PubMed ID: 26758433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CADM2/Akt pathway is involved in the inhibitory effect of miR-21-5p downregulation on proliferation and apoptosis in esophageal squamous cell carcinoma cells.
    Li X; Chen D; Li M; Gao X; Shi G; Zhao H
    Chem Biol Interact; 2018 May; 288():76-82. PubMed ID: 29680210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sp1-mediated transcriptional activation of miR-205 promotes radioresistance in esophageal squamous cell carcinoma.
    Pan F; Mao H; Bu F; Tong X; Li J; Zhang S; Liu X; Wang L; Wu L; Chen R; Wei H; Li B; Li C; Yang Y; Steer CJ; Zhao J; Guo Y
    Oncotarget; 2017 Jan; 8(4):5735-5752. PubMed ID: 27974696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway.
    Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P
    Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulated miR-26a promotes proliferation, migration, and invasion
    Yang C; Zheng S; Liu T; Liu Q; Dai F; Zhou J; Chen Y; Sheyhidin I; Lu X
    FASEB J; 2017 May; 31(5):2114-2122. PubMed ID: 28174206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-214 inhibits the proliferation and invasion of esophageal squamous cell carcinoma cells by targeting CDC25B.
    Wang M; Wang L; Zhang M; Li X; Zhu Z; Wang H
    Biomed Pharmacother; 2017 Nov; 95():1678-1683. PubMed ID: 28954387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway.
    Zhao Y; Ma K; Yang S; Zhang X; Wang F; Zhang X; Liu H; Fan Q
    Int J Oncol; 2018 Aug; 53(2):644-658. PubMed ID: 29767234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mir-192 suppresses apoptosis and promotes proliferation in esophageal aquamous cell caicinoma by targeting Bim.
    Li S; Li F; Niu R; Zhang H; Cui A; An W; Wang X
    Int J Clin Exp Pathol; 2015; 8(7):8048-56. PubMed ID: 26339371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SQLE induces epithelial-to-mesenchymal transition by regulating of miR-133b in esophageal squamous cell carcinoma.
    Qin Y; Zhang Y; Tang Q; Jin L; Chen Y
    Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):138-148. PubMed ID: 28069586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-650 Promotes the Metastasis and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Directly Inhibiting LATS2 Expression.
    Han LL; Yin XR; Zhang SQ
    Cell Physiol Biochem; 2018; 51(3):1179-1192. PubMed ID: 30481780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-125b-5p functions as a tumor suppressor gene partially by regulating HMGA2 in esophageal squamous cell carcinoma.
    Mei LL; Wang WJ; Qiu YT; Xie XF; Bai J; Shi ZZ
    PLoS One; 2017; 12(10):e0185636. PubMed ID: 28968424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma.
    Song Y; Li J; Zhu Y; Dai Y; Zeng T; Liu L; Li J; Wang H; Qin Y; Zeng M; Guan XY; Li Y
    Oncotarget; 2014 Nov; 5(22):11669-80. PubMed ID: 25375090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 131.